Jeffrey L. Wade - Feb 10, 2022 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
President and CFO
Signature
/s/ Jeffrey L. Wade
Stock symbol
LXRX
Transactions as of
Feb 10, 2022
Transactions value $
$0
Form type
4
Date filed
2/14/2022, 03:08 PM
Previous filing
Feb 11, 2022
Next filing
Feb 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +335K $0.00 335K Feb 10, 2022 Common Stock 335K $3.20 Direct F1
transaction LXRX Restricted Stock Units Award $0 +112K $0.00 112K Feb 10, 2022 Common Stock 112K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.